Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 4 , Pages 356-367 , April 2010

Neural Mechanisms of Interference Control and Time Discrimination in Attention-Deficit/Hyperactivity Disorder

  • Timo D. Vloet, M.D.

      Affiliations

    • Cognitive Neurology Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich
    • Aachen University, Germany
    • Corresponding Author InformationCorrespondence to Dr. Timo D. Vloet, Department of Child and Adolescent Psychiatry, Neuenhofer Weg 21, D-52074 Aachen, Germany
    • ,
  • Susanne Gilsbach, M.D.

      Affiliations

    • Cognitive Neurology Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich
    • Aachen University, Germany
    • ,
  • Susanne Neufang, Ph.D.

      Affiliations

    • Cognitive Neurology Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich
    • Aachen University, Germany
    • ,
  • Gereon R. Fink, M.D

      Affiliations

    • Cognitive Neurology Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich
    • University Hospital Cologne
    • ,
  • Beate Herpertz-Dahlmann, M.D.

      Affiliations

    • Aachen University, Germany
    • ,
  • Kerstin Konrad, Ph.D.

      Affiliations

    • Cognitive Neurology Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich
    • Aachen University, Germany

,Accepted 22 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was supported by a grant to K.K. and B.H.-D. by the Deutsche Forschungsgemeinschaft (DFG-KFO112-II, TP5).

 Disclosure: Dr. Herpertz-Dahlmann serves as a consultant for Eli Lilly & Company, and has received research support from AstraZeneca, Eli Lilly & Company, Novartis, and Janssen Cilag. Drs. Vloet, Gilsbach, Neufang, Fink, and Konrad report no biomedical financial interests or potential conflicts of interest.

PII: S0890-8567(10)00078-X

doi: 10.1016/j.jaac.2010.01.004

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 4 , Pages 356-367 , April 2010

Article Tools

* Image Usage & Resolution